Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase 'AMP-activated protein kinase/Forkhead box protein O3A pathway' refers to a functional signaling interaction between two distinct proteins: AMP-activated protein kinase (AMPK) and Forkhead box protein O3A (FOXO3A). It is not a single molecular target or receptor. AMPK is a cellular energy sensor and kinase, while FOXO3A is a transcription factor. Their functional relationship, the AMPK–FOXO3A pathway, defines how AMPK phosphorylates and activates FOXO3A in response to metabolic and oxidative stress, coordinating cellular responses such as gene activation for stress response, DNA repair, and antioxidant systems. As such, therapeutic approaches typically target the individual components (AMPK or indirectly FOXO3A) rather than the 'pathway' as a singular, discrete entity.
This 'pathway' describes the functional interaction where AMP-activated protein kinase (AMPK) phosphorylates and activates Forkhead box protein O3A (FOXO3A) in response to metabolic stress. Drugs modulate the activity of the individual components of this pathway (AMPK or FOXO3A), thereby influencing the overall pathway's signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMP-activated protein kinase – Forkhead box protein O3A pathway (AMPK–FOXO3A pathway).